Sign in Subscribe
Cancer

New Hereditary Condition Affects DNA Repair, Impacts Chemotherapy Response

Strategic Insights

— 1 min read

A team of researchers led by cancer genetics experts at the University of Birmingham has discovered a new hereditary condition, DIAL syndrome, which affects patients' ability to repair DNA. This condition leaves them at a greater risk of developing blood cancer and impairs their ability to repair damage caused by chemotherapy treatments. The condition is caused by mutations in the DIAPH1 gene, which produces a protein essential for cell repair.

DIAL syndrome causes clinical symptoms similar to other known chromosome 'breakage' disorders, and patients are typically affected in the first few years of life. The lack of DIAPH1 impairs the body's ability to regulate B cell development and function, increasing the risk of developing B-cell Lymphoma. As DNA-damaging treatments like radiotherapy and chemotherapy can cause irreparable damage to normal cells, DIAL syndrome patients are unable to repair this damage.

Key Takeaways:

  • DIAL syndrome is a new hereditary condition that affects patients' ability to repair DNA, increasing their risk of developing blood cancer and impairing their response to chemotherapy.
  • The condition is caused by mutations in the DIAPH1 gene, which produces a protein essential for cell repair.
  • DIAL syndrome causes symptoms similar to other known chromosome 'breakage' disorders and typically affects patients in the first few years of life.
  • The lack of DIAPH1 impairs the body's ability to regulate B cell development and function, increasing the risk of developing B-cell Lymphoma.
  • DIAL syndrome patients are unable to repair damage caused by chemotherapy and radiotherapy, leading to life-threatening side effects.
  • Researchers are working to identify more patients and families affected by DIAL syndrome, develop biomarkers, and explore treatments.
  • The discovery of DIAL syndrome provides a diagnosis for a previously unrecognised genetic condition and informs parents and medical professionals about disease progression and cancer risk.

Statistics:

  • The condition affects DNA repair in patients.
  • DIAL syndrome increases the risk of developing blood cancer by X%.
  • The lack of DIAPH1 impairs the body's ability to regulate B cell development and function by Y%.
  • Researchers identified 33 patients with mutations in the DIAPH1 gene.
  • The condition typically affects patients in the first few years of life.
  • Research suggests that chemotherapy and radiotherapy can cause irreparable damage to normal cells.

Sources:

  • Published paper in Nature Communications.
  • University of Birmingham press release.
  • Cancer Research UK website.
  • Professor Grant Stewart's University of Birmingham page.
  • Professor Henry Houlden's University College London page.

Read more